Accelerated_fractionation_radiation_therapy_for_advanced_squamous_cell_carcinoma_of_the_head_and_neck._We_treated_14_patients_who_had_advanced_head_and_neck_cancer_with_an_accelerated_fractionation_schedule_of_irradiation_consisting_of_two_fractions_given_6_hours_apart._In_the_morning_a_volume_of_1.7_Gy_was_given_to_an_area_that_encompassed_the_entire_tumor,_enlarged_lymph_nodes,_and_all_areas_at_risk_for_microscopic_disease._Six_hours_later,_1.1_Gy_was_given_to_an_area_that_included_only_the_tumor_and_any_enlarged_lymph_nodes,_with_a_2-cm_margin._The_treatment_was_well_tolerated;_of_the_13_patients_who_completed_therapy,_six_did_not_require_a_break_in_therapy,_and_seven_patients_did._The_median_rest_period_was_2_days._There_was_no_grade_4_toxicity._Grade_3_toxicity_included_skin_changes_(one_case),_mucositis_(two),_dysphagia_(two),_weight_loss_(three),_and_a_decrease_in_the_hemoglobin_level_(one_case)._The_response_rate_in_the_13_who_completed_therapy_was_13/13_(100%);_11_of_the_13_(83%)_had_a_complete_response._Only_one_of_the_11_who_achieved_a_complete_response_had_failure_at_the_primary_site._At_a_median_follow-up_of_24_months,_the_absolute_survival_was_7/13_(54%)_and_the_corrected_survival_was_7/10_(70%)._This_technique_permits_radiation_therapy_to_be_given_on_an_accelerated_schedule_without_a_planned_break_in_treatment._The_overall_response_rate_and_survival_at_2_years_was_excellent.